Main Quotes Calendar Forum
flag

FX.co ★ Quest Diagnostics To Acquire Select Assets Of PathAI Diagnostics - Quick Facts

back back next
typeContent_19130:::2024-05-01T12:25:00

Quest Diagnostics To Acquire Select Assets Of PathAI Diagnostics - Quick Facts

Quest Diagnostics, a diagnostics information services provider, and PathAI, an artificial intelligence technology provider for pathology, are joining forces to expedite the integration of digital and AI pathology breakthroughs. This collaboration aims to enhance efficiency in diagnosing diseases, particularly cancer. Quest will secure select assets of PathAI Diagnostics, the branch of PathAI that delivers anatomic and digital pathology lab services.

In addition, Quest will license PathAI's AISight, a digital pathology image management system. This licensing will benefit Quest's pathology labs and client sites throughout the United States. Moreover, Quest will be the favored provider for PathAI's clinical lab services for biopharmaceuticals.

For further health news, visit rttnews.com.

Share this article:
back back next
loader...
all-was_read__icon
You have watched all the best publications
presently.
We are already looking for something interesting for you...
all-was_read__star
Recently published:
loader...
More recent publications...